Vfend and condition aggravated 
Vfend and condition aggravated Patient Reports February 12, 2012
Vfend Side Effects Report #4866915-5
Vfend side effect was reported by a Physician from JAPAN on Dec 09, 2005. Female patient, 35 years of age, was diagnosed with systemic mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, dialysis
, multi-organ failure, renal impairment. Vfend dosage: 150 MG (150 MG, 1 IN 1 D), INTRAVENOUS. During the same period patient was treated with ZOVIRAX, MEROPEN, FOSFLUCONAZOLE. Patient died on 11/17/2005.Vfend Side Effects Report #4765790-7
Vfend side effect was reported by a Pharmacist from JAPAN on Aug 22, 2005. Male patient, 73 years of age, was diagnosed with systemic candida and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, dizziness
, tinnitus , vomiting. Vfend dosage: 600 MG, ORAL. During the same period patient was treated with CIPROFLOXACIN HYDROCHLORIDE. Patient died on 08/19/2005.Vfend Side Effects Report #4948440-6
Vfend side effect was reported by a Physician from JAPAN on Feb 28, 2006. Female patient, 80 years of age, was diagnosed with sepsis
, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, liver function test abnormal. Vfend dosage: 200 MG, INTRAVENOUS. During the same period patient was treated with PRODIF, TIENAM, CARBENIN. Patient died on 02/25/2006.Vfend Side Effects Report #5369665-4
Vfend side effect was reported by a Physician from JAPAN on June 13, 2007. Female patient, 86 years of age, was diagnosed with respiratory moniliasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, convulsion, hepatic function abnormal. Vfend dosage: DAILY DOSE:400MG. Patient died on 06/01/2007.
Vfend Side Effects Report #5109490-2
Vfend side effect was reported by a Physician from JAPAN on Sept 06, 2006. Male patient, 77 years of age, was diagnosed with pulmonary mycosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: asthenia, blood alkaline phosphatase increased, condition aggravated, decreased appetite, optic neuritis, pulmonary mycosis, white blood cell count decreased. Vfend dosage: 300 MG (150 MG, 2 IN 1 D), ORAL. During the same period patient was treated with GASTER D, LEVOFLOXACIN, CLARITHROMYCIN, PERDIPIN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4901225-9
Vfend side effect was reported by a Physician from JAPAN on Jan 19, 2006. Male patient, 79 years of age, weighting 158.3 lb, was diagnosed with pneumonia fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cellulitis
, coma, condition aggravated, depressed level of consciousness, hypoxia, liver disorder, miosis, paresis. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with MAXIPIME, MINOCYCLINE, ORGARAN, PIPERACILLIN, IDAMYCIN, CYTARABINE, KYTRIL. Patient died on 11/28/2005.Vfend Side Effects Report #5167363-3
Vfend side effect was reported by a Physician from JAPAN on Nov 17, 2006. Male patient, 51 years of age, was diagnosed with pneumonia fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, lung disorder. Vfend dosage: unknown. Patient recovered.
Vfend Side Effects Report #5221300-1
Vfend side effect was reported by a Physician from JAPAN on Jan 15, 2007. Male patient, weighting 90.39 lb, was diagnosed with pneumonia fungal and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspiration, condition aggravated, interstitial lung disease, pneumothorax. Vfend dosage: DAILY DOSE:800MG. During the same period patient was treated with DIFLUCAN, MAXIPIME, MEROPEN. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #4889585-9
Vfend side effect was reported by a Physician from JAPAN on Jan 10, 2006. Male patient, 71 years of age, weighting 125.4 lb, was diagnosed with mycotic corneal ulcer, prophylaxis and was treated with Vfend. After drug was administered, patient experienced the following side effects: aortic valve incompetence, bundle branch block left, bundle branch block right, cardiac failure, cardiac valve disease, condition aggravated, corneal epithelium disorder, corneal opacity, eye infection
. Vfend dosage: 320 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE, ATROPINE, OFLOXACIN, ZOVIRAX, PRODIF, GATIFLOXACIN, SULPELIN, VANCOMYCIN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4885954-1
Vfend side effect was reported by a Physician from JAPAN on Jan 05, 2006. Female patient was diagnosed with mucormycosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, condition aggravated, mucormycosis. Vfend dosage: unknown. Patient died.
Vfend Side Effects Report #4988047-8
Vfend side effect was reported by a Pharmacist from JAPAN on Apr 14, 2006. Male patient, 80 years of age, was diagnosed with ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergilloma, condition aggravated, hepatic function abnormal. Vfend dosage: unknown. During the same period patient was treated with PLETAL. Patient died on 04/15/2006.
Vfend Side Effects Report #4752389-1
Vfend side effect was reported by a Physician from JAPAN on Aug 10, 2005. Female patient, 75 years of age, was diagnosed with ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, pleurisy. Vfend dosage: unknown. Patient died on 08/02/2005.
Vfend Side Effects Report #5044446-X
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Male patient, 73 years of age, was diagnosed with ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: accommodation disorder, condition aggravated, delusion, hallucination, visual, insomnia. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with TAMSULOSIN, UBRETID, BESACOLIN, LANIRAPID, MEXITIL, PURSENNID. Patient died.
Vfend Side Effects Report #5045905-6
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Male patient, 73 years of age, was diagnosed with ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: abnormal behaviour, accommodation disorder, condition aggravated, delusion, hallucination, visual, insomnia, visual disturbance. Vfend dosage: unknown. During the same period patient was treated with TAMSULOSIN, UBRETID, BESACOLIN, LANIRAPID, MEXITIL, PURSENNID. Patient died.
Vfend Side Effects Report #4967206-4
Vfend side effect was reported by a Physician from UNITED STATES on Mar 18, 2006. Female patient, 65 years of age, weighting 175.0 lb, was diagnosed with idiopathic pulmonary fibrosis, osteoarthritis
and was treated with Vfend. After drug was administered, patient experienced the following side effects: cataract , condition aggravated, glaucoma , ill-defined disorder, lung disorder, pain , sleep disorder , visual acuity reduced, visual disturbance. Vfend dosage: 400 MG (200 MG, 2 IN 1 D). During the same period patient was treated with CELEBREX, PREDNISONE, ACTIMMUNE, NEURONTIN, PRAVACHOL, FOSAMAX, PREVACID, ACETYLCYSTEINE. Patient recovered.Vfend Side Effects Report #4805437-4
Vfend side effect was reported by a Physician from JAPAN on Oct 05, 2005. Male patient, 78 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, dialysis , interstitial lung disease, renal failure acute. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISONE, BAKTAR, OMEPRAZOLE. Patient died on 09/30/2005.Vfend Side Effects Report #4919915-0
Vfend side effect was reported by a Physician from JAPAN on Feb 07, 2006. Male patient, 75 years of age, weighting 125.0 lb, was diagnosed with fungal infection
, staphylococcal infection and was treated with Vfend. After drug was administered, patient experienced the following side effects: candidiasis, condition aggravated, dialysis , gastrointestinal haemorrhage, hepatic failure, pancreatitis, renal failure. Vfend dosage: 400 MG (200 MG 2 IN 1 D INTRAVENOUS. During the same period patient was treated with TARGOCID, HABEKACIN, GLUCOSE, STRONG NEO MINOPHAGEN C, AMIYU, TATHION, KAYTWO N, MULTAMIN. Patient died on 12/13/2005.Vfend Side Effects Report #5301407-0
Vfend side effect was reported by a Physician from JAPAN on Apr 06, 2007. Male patient, 73 years of age, weighting 99.21 lb, was diagnosed with fungal infection
, bacterial infection , staphylococcal infection and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, fungal infection , lymphoma , neoplasm malignant, pathogen resistance, staphylococcal infection . Vfend dosage: DAILY DOSE:300MG. During the same period patient was treated with BACTRIM, VANCOMYCIN. Patient died on 03/21/2007.Vfend Side Effects Report #5062830-5
Vfend side effect was reported by a Pharmacist from JAPAN on July 12, 2006. Male patient, 53 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute leukaemia, condition aggravated, vision blurred, visual disturbance. Vfend dosage: 300 MG, ORAL. During the same period patient was treated with AMIKACIN SULPHATE, SULFAMETHOXAZOLE. Patient died on 10/18/2005.Vfend Side Effects Report #5062888-3
Vfend side effect was reported by a Pharmacist from JAPAN on July 12, 2006. Male patient, 52 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection , condition aggravated, myelodysplastic syndrome, photophobia. Vfend dosage: unknown. During the same period patient was treated with MAXIPIME, PREDNISOLONE, CYTARABINE, VEPESID, TAZOCIN. Patient died on 12/15/2005.Vfend Side Effects Report #5062822-6
Vfend side effect was reported by a Pharmacist from JAPAN on July 12, 2006. Female patient, 42 years of age, was diagnosed with fungal infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, MAXIPIME, TARGOCID. Patient died on 02/11/2006.Vfend Side Effects Report #4916741-3
Vfend side effect was reported by a Physician from JAPAN on Feb 01, 2006. Male patient, 85 years of age, weighting 98.55 lb, was diagnosed with fungaemia and was treated with Vfend. After drug was administered, patient experienced the following side effects: bedridden, cardiac arrest
, cerebral infarction, condition aggravated, pneumonia , renal failure acute, respiratory arrest, respiratory failure. Vfend dosage: unknown. During the same period patient was treated with PRODIF, MICAFUNGIN, MAXIPIME, MEROPEN, CIPROFLOXACIN HYDROCHLORIDE, UNASYN. Patient was hospitalized. Patient died on 01/25/2006.Vfend Side Effects Report #5637323-4
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on Feb 13, 2008. Female patient, 71 years of age, weighting 143.5 lb, was diagnosed with febrile neutropenia and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, c-reactive protein increased, condition aggravated. Vfend dosage: unknown. During the same period patient was treated with DIFLUCAN, ALFAROL, GLAKAY, ZANTAC, ULCERLMIN, TANNALBIN, POLYMYXIN B SULPHATE. Patient died on 05/14/2007.
Vfend Side Effects Report #4868785-8
Vfend side effect was reported by a Physician from JAPAN on Dec 15, 2005. Male patient, 78 years of age, weighting 172.0 lb, was diagnosed with candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, haemodialysis, interstitial lung disease, metabolic acidosis, renal failure acute, respiratory failure, trichosporon infection. Vfend dosage: unknown. During the same period patient was treated with PREDNISOLONE, COTRIM, OMEPRAZOLE, MICAFUNGIN, TIENAM, DORMICUMECTION, AMINOTRIPA. Patient was hospitalized and became disabled. Patient died on 09/30/2005.
Vfend Side Effects Report #5269313-8
Vfend side effect was reported by a Physician from JAPAN on Mar 07, 2007. Male patient, weighting 123.5 lb, was diagnosed with candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: candidiasis, condition aggravated, depressed level of consciousness, epilepsy
, guillain-barre syndrome , hepatic failure, no therapeutic response. Vfend dosage: unknown. During the same period patient was treated with PRODIF, SULPERAZON, IMMUNE GLOBULIN INTRAVENOUS, CYCLOSPORINE, VANCOMYCIN, PAZUFLOXACIN, IMMUNOGLOBULINS, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 01/29/2007.Vfend Side Effects Report #4866919-2
Vfend side effect was reported by a Physician from BRAZIL on Dec 12, 2005. Male patient was diagnosed with candidiasis and was treated with Vfend. After drug was administered, patient experienced the following side effects: candidiasis, condition aggravated, hallucination, visual. Vfend dosage: 200 MG (200 MG 1 IN 1 D) INTRAVENOUS. During the same period patient was treated with CORTICOSTEROID, ANTIBIOTICS. Patient was hospitalized. Patient died on 12/01/2005.
Vfend Side Effects Report #4920580-7
Vfend side effect was reported by a Physician from SWITZERLAND on Feb 07, 2006. Female patient was diagnosed with candida sepsis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, enterococcal infection, injury, liver disorder, peritonitis, pleural effusion, respiratory distress, respiratory failure. Vfend dosage: 200 MG (200 MG, EVERY DAY), ORAL. During the same period patient was treated with VANCOMYCIN, OMEPRAZOLE, GLAGYLLET, MAXIPIME, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Vfend Side Effects Report #5062889-5
Vfend side effect was reported by a Pharmacist from JAPAN on July 12, 2006. Female patient, 80 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, photophobia. Vfend dosage: unknown. During the same period patient was treated with FIRSTCIN, CARBENIN, SULFAMETHOXAZOLE, FAMOTIDINE, DEPAS. Patient died on 09/16/2005.
Vfend Side Effects Report #5104038-0
Vfend side effect was reported by a Physician from JAPAN on Aug 28, 2006. Male patient, 77 years of age, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection
, blood pressure decreased, body temperature increased, bronchopulmonary aspergillosis, condition aggravated, dehydration, heart rate decreased, hyperthermia, hypokalaemia. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.Vfend Side Effects Report #5118563-X
Vfend side effect was reported by a Physician from JAPAN on Sept 15, 2006. Male patient, 77 years of age, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection
, blood pressure decreased, bronchopulmonary aspergillosis, condition aggravated, dehydration, hyperthermia, hypokalaemia, oral intake reduced. Vfend dosage: 400 MG, ORAL. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.Vfend Side Effects Report #4821187-2
Vfend side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 21, 2005. Female patient, 61 years of age, weighting 148.0 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: chromatopsia, condition aggravated, dyspepsia, dyspnoea, psychomotor hyperactivity. Vfend dosage: 40 MG (20 MG, 2 IN 1 D). During the same period patient was treated with AMIKACIN, ITRACONAZOLE, LORATADINE, METHYLPREDNISOLONE, CLONIDINE, BENADRYL, VITAMIN, VITAMIN A. Patient recovered.
Vfend Side Effects Report #5045942-1
Vfend side effect was reported by a Physician from JAPAN on June 16, 2006. Female patient, 61 years of age, weighting 114.2 lb, was diagnosed with bronchopulmonary aspergillosis, pneumocystis jiroveci pneumonia, sedation, pain
and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, opportunistic infection. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with SULFAMETHOXAZOLE, DORMICUMECTION, LEPETAN, CARBENIN, MINOCYCLINE, ALENDRONATE, VIT K CAP, ZANTAC. Patient was hospitalized. Patient died on 05/17/2006.Vfend Side Effects Report #4859960-7
Vfend side effect was reported by a Physician from JAPAN on Dec 02, 2005. Female patient, 59 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anuria, condition aggravated, haemorrhagic cerebral infarction, pneumonia aspergillus, rash
. Vfend dosage: 360 MG (180 MG, BID), INTRAVENOUS. Patient died.Vfend Side Effects Report #5144581-1
Vfend side effect was reported by a Physician from JAPAN on Oct 18, 2006. Male patient, 57 years of age, weighting 112.4 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, bronchopulmonary aspergillosis, cardiac arrest
, condition aggravated, eye rolling, feeling abnormal, heart rate decreased. Vfend dosage: 400 MG (200 MG, FREQUENCY: BID), INTRAVENOUS. During the same period patient was treated with CEFTAZIDIME, FIRSTCIN, CARBENIN, SAXIZON, OMEPRAL, MUCOSTA, LASIX, FUNGIZONE. Patient was hospitalized. Patient died on 09/05/2006.Vfend Side Effects Report #5153652-5
Vfend side effect was reported by a Physician from JAPAN on Nov 02, 2006. Male patient, 57 years of age, weighting 112.4 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: blood pressure immeasurable, bronchopulmonary aspergillosis, cardiac arrest
, condition aggravated, hodgkin's disease , hypoglycaemia, loss of consciousness, lymphadenitis. Vfend dosage: 400 MG (200 MG, FREQUENCY: BID), INTRAVENOUS. During the same period patient was treated with AMINOPHYLLINE, MODACIN, FIRSTCIN, CARBENIN, SAXIZON, OMEPRAL, MUCOSTA, LASIX. Patient was hospitalized. Patient died on 09/05/2006.Vfend Side Effects Report #4717282-9
Vfend side effect was reported by a Physician from FRANCE on July 04, 2005. Female patient, 57 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, cytolytic hepatitis, liver disorder, pulmonary embolism
. Vfend dosage: 400 MG (200 MG, 2 IN 1 D). During the same period patient was treated with PHENOXYMETHYL PENICILLIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4752392-1
Vfend side effect was reported by a Physician from JAPAN on Aug 10, 2005. Female patient, 54 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hallucination, hallucination, auditory, pleural effusion, pneumonia
, respiratory failure, xanthopsia. Vfend dosage: 400 MG (2 IN 1 D), INTRAVENOUS. Patient died on 08/01/2005.Vfend Side Effects Report #5018189-2
Vfend side effect was reported by a Physician from JAPAN on May 17, 2006. Male patient, 51 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, interstitial lung disease, shock. Vfend dosage: 300 MG, INTRAVENOUS. During the same period patient was treated with MINOCYCLINE, GANCICLOVIR, MEROPEN, ACYCLOVIR, BACTRIM. Patient died on 10/31/2005.
Vfend Side Effects Report #5271673-9
Vfend side effect was reported by a Physician from JAPAN on Sept 15, 2006. Male patient, weighting 92.59 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, pyrexia, rhabdomyolysis. Vfend dosage: DAILY DOSE:400MG. During the same period patient was treated with CEFOBID, POTACOL. Patient died on 08/05/2006.
Vfend Side Effects Report #6013827-X
Vfend side effect was reported by a Physician from KOREA, REPUBLIC OF on Dec 08, 2008. Female patient was diagnosed with bronchopulmonary aspergillosis, pneumonia
, diabetes mellitus, prophylaxis against gastrointestinal ulcer, immunosuppression and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, septic shock. Vfend dosage: 200 MG, 2X/DAY. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, METFORMIN, FAMOTIDINE, VOGLIBOSE, CYCLOSPORINE, TRIMAPRIM. Patient recovered.Vfend Side Effects Report #4874841-0
Vfend side effect was reported by a Physician from JAPAN on Dec 20, 2005. Female patient was diagnosed with bronchopulmonary aspergillosis, atrial fibrillation
and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, delirium, dizziness , haemorrhagic diathesis, international normalised ratio increased, nausea , pulmonary haemorrhage. Vfend dosage: 400 MG, ORAL; 200 MG, ORAL. During the same period patient was treated with WARFARIN, ITRACONAZOLE. Patient recovered.Vfend Side Effects Report #4700620-0
Vfend side effect was reported by a Physician from on June 13, 2005. Female patient was diagnosed with brain abscess, granuloma, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: brain abscess, cholestasis, condition aggravated. Vfend dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ACETAMINOPHEN, BACTRIM, FRAXIPARINE, ZOFRAN, NEXIUM, MERONEM. Patient recovered.
Vfend Side Effects Report #5127562-3
Vfend side effect was reported by a Physician from JAPAN on Sept 25, 2006. Male patient, 71 years of age, weighting 111.1 lb, was diagnosed with bacterial infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: bacterial infection , condition aggravated, dyspnoea, interstitial lung disease, lung infiltration, metastases to bone, metastases to lung, multiple myeloma , oxygen saturation decreased. Vfend dosage: 140 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with PURSENNID, OMEPRAZOLE, TAMSULOSIN, LOXONIN, APLACE, MAGNESIUM OXIDE, TETRAMIDE. Patient was hospitalized. Patient died on 08/25/2006.Vfend Side Effects Report #5132427-7
Vfend side effect was reported by a Physician from JAPAN on Oct 04, 2006. Male patient, 71 years of age, weighting 111.1 lb, was diagnosed with aspergillosis, bacterial infection
and was treated with Vfend. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, condition aggravated, interstitial lung disease, multiple myeloma , pneumocystis jiroveci pneumonia. Vfend dosage: 140 MG (2 IN 1 D), INTRAVENOUS. During the same period patient was treated with MAXIPIME, PURSENNID, OMEPRAZOLE, TAMSULOSIN, LOXONIN, APLACE, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 08/26/2006.Vfend Side Effects Report #4921191-X
Vfend side effect was reported by a Physician from JAPAN on Feb 06, 2006. Male patient, 70 years of age, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic failure, mucormycosis. Vfend dosage: unknown. Patient died.
Vfend Side Effects Report #5909276-2
Vfend side effect was reported by a Consumer or non-health professional from JAPAN on Sept 24, 2008. Male patient, 67 years of age, weighting 114.6 lb, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, mucormycosis, thrombocytopenia. Vfend dosage: DAILY DOSE:6MG/KG. During the same period patient was treated with NEORAL, COTRIM, PREDONINE. Patient was hospitalized. Patient died on 07/04/2006.
Vfend Side Effects Report #4896785-0
Vfend side effect was reported by a Physician from JAPAN on Jan 13, 2006. Female patient, 67 years of age, weighting 138.5 lb, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, cholestasis, condition aggravated, disseminated intravascular coagulation, duodenal perforation, fungal infection , hepatic function abnormal. Vfend dosage: 720 MG (360 MG, 2 IN 1D), INTRAVENOUS; 360 MG (180 MG, 2 IN 1 D), INTRAVENOUS. During the same period patient was treated with PREDNISONE, NIFEDIPINE, NIZATIDINE, LOXOPROFEN, UBIDECARENONE, MECOBALAMIN, TRIAZOLAM. Patient was hospitalized. Patient died on 12/08/2005.Vfend Side Effects Report #4906225-0
Vfend side effect was reported by a Physician from JAPAN on Jan 25, 2006. Male patient, 67 years of age, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, aspergillosis, condition aggravated. Vfend dosage: 6 MG/KG, INTRAVENOUS. Patient died on 01/01/2006.
Vfend Side Effects Report #4916942-4
Vfend side effect was reported by a Physician from JAPAN on Feb 01, 2006. Male patient, 67 years of age, weighting 110.2 lb, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, aspergillosis, condition aggravated. Vfend dosage: 6 MG/KG, INTRAVENOUS. Patient died on 01/01/2006.
Vfend Side Effects Report #5019747-1
Vfend side effect was reported by a Physician from JAPAN on May 22, 2006. Female patient, 61 years of age, was diagnosed with aspergillosis, brain abscess and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, myelodysplastic syndrome. Vfend dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, MICAFUNGIN. Patient died.
Vfend Side Effects Report #4609340-4
Vfend side effect was reported by a Physician from on Mar 01, 2005. Female patient, 52 years of age, was diagnosed with aspergillosis and was treated with Vfend. After drug was administered, patient experienced the following side effects: biopsy liver abnormal, cerebral fungal infection, condition aggravated, fungus sputum test positive, immunosuppression, liver disorder, lung disorder, nervous system disorder. Vfend dosage: unknown. During the same period patient was treated with CASPOFUNGIN ACETATE, IMMUNOSUPPRESSIVE AGENTS, CORTICOSTEROIDS. Patient was hospitalized. Patient died on 09/20/2003.
Vfend Side Effects Report #4562663-X
Vfend side effect was reported by a Health Professional from on Jan 11, 2005. Male patient, 51 years of age, was diagnosed with aspergillosis, ill-defined disorder and was treated with Vfend. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood urea increased, condition aggravated, confusional state, cough, feeling drunk, hepatic cirrhosis, hypoglycaemia. Vfend dosage: unknown. During the same period patient was treated with TEMAZEPAM, DICLOFENAC, CODEINE PHOSPHATE AND ACETAMINOPHEN, DOTHIEPIN HYDROCHLORIDE. Patient died.
Vfend Side Effects Report #5177095-3
Vfend side effect was reported by a Health Professional from FRANCE on Nov 27, 2006. Male patient, 19 years of age, weighting 110.2 lb, was diagnosed with aspergillosis, candidiasis, lung transplant
and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic failure, renal failure. Vfend dosage: 400 MG (200 MG, 2 IN 1 D), ORAL. During the same period patient was treated with FLUCONAZOLE, CELLCEPT, CYCLOSPORINE, CEFTAZIDIME PENTAHYDRATE, CIPROFLOXACIN, ORBENIN CAP, ZOFRAN. Patient was hospitalized. Patient recovered.Vfend Side Effects Report #4818923-8
Vfend side effect was reported by a Physician from JAPAN on Oct 20, 2005. Female patient, 77 years of age, was diagnosed with aspergilloma and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, lung neoplasm malignant. Vfend dosage: 400 MG, INTRAVENOUS. Patient recovered.
Vfend Side Effects Report #4772827-8
Vfend side effect was reported by a Physician from JAPAN on Sept 06, 2005. Male patient, 55 years of age, weighting 66.14 lb, was diagnosed with aspergilloma and was treated with Vfend. After drug was administered, patient experienced the following side effects: condition aggravated, pulmonary fibrosis
. Vfend dosage: 200 MG (100 MG, BID INTERVAL: EVERY DAY), ORAL. Patient died on 09/01/2005.Vfend Side Effects Report #5146288-3
Vfend side effect was reported by a Physician from JAPAN on Oct 19, 2006. Male patient, 87 years of age, was treated with Vfend. After drug was administered, patient experienced the following side effects: aspergillosis, blood alkaline phosphatase increased, blood bilirubin increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, interstitial lung disease. Vfend dosage: 400 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, IMMUNOSUPPRESSIVE AGENTS. Patient died on 10/01/2006.